Human cells unable to express decoron produced disorganized extracellular matrix lacking 'shape modules' (interfibrillar proteoglycan bridges)

Experimental Cell Research

Volumn 243, Issue 1, 1998, Pages 59-66

  Scott, John E ^a   Dyne, Katharine M ^b   Thomlinson, Alison M ^a   Ritchie, Mark ^a   Bateman, John ^c   Cetta, Giuseppe ^b   Valli, M ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Biglycon; Collagen; Dermatan sulfate; Osteogenesis imperfecta

Indexed keywords

CHONDROITIN SULFATE; COLLAGEN; DECORON; DERMATAN SULFATE; HYALURONIC ACID; KERATAN SULFATE; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; COLLAGEN METABOLISM; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ANALYSIS;

EID: 0032566308     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4089     Document Type: Article

References (33)

1. Scott, J. E. (1975) Composition and structure of the pericellular environment: Physiological function and chemical composition of pericellular proteoglycan (an evolutionary view). Philos. Trans. R. Soc. London B 271, 235-242.
2. Scott, J. E. (1995) Extracellular matrix, supramolecular organisation and shape. J. Anat. 187, 259-269.
3. Scott, J. E. (1991) Proteoglycan:collagen interactions and corneal ultrastructure. Biochem. Soc. Trans. 19, 877-881.
4. Scott, J. E. (1992) Supramolecular organisation of extracellular matrix glycosaminoglycans, in vitro and in the tissues. FASEB J. 6, 2639-2645.
5. Scott, J. E. (1996) Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped: Implications for their interactions with collagen. Biochemistry 35, 8795-8799.
6. Scott, J. E. (1996) Extracellular matrix, supramolecular organisation and shape: Dynamic aspects. In "Advances in Biomedical Studies, Vol II, Biology and Physiopathology of the Extracellular Matrix" (C. Balduini, P. Cherubino, and G. De Luca, Eds.), pp. 7 to 19, La Goliardica Pavese, Pavia.
7. Scott, J. E., Bosworth, T. R., Cribb, A. M., and Gressner, A. M. (1994) The chemical morphology of extracellular matrix in experimental rat liver fibrosis resembles that of normal developing connective tissue. Virchow's Arch. 424, 89-98.
8. Scott, J. E., Haigh, M., Nusgens, B., and Lapierre, C. (1989) Proteoglycan:collagen interactions in dermatosparactic skin and tendon: An electron histochemical study using Cupromeronic blue in a critical electrolyte concentration method. Matrix 9, 437-442.
9. Scott, J. E., and Tenni, R. (1997) Osteogenesis imperfecta mutations may probe vital functional domains (e.g., proteoglycan binding sites) of type I collagen fibrils. Cell Biochem. Funct. 15, 283-286.
10. Danielson, K. G., Baribault, H., Holmes, D. F., Graham, H., Kadler, K., and Iozzo, R. V. (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136, 729-743.
11. Dyne, K. M., Valli, M., Forlino, A., Mottes, M., Kresse, H., and Cetta, G. (1996) Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta. Am. J. Med. Genet. 63, 161-166.
12. Dyne, K., Valli, M., Cetta, G., Scott, J. E., Thomlinson, A. M., and Ritchie, M. (1996) Evidence for altered proteoglycan-collagen interactions in extracellular matrices produced by osteogenesis imperfecta skin fibroblasts. Eur. J. Histochem. 40, 246.
13. Nicholls, A. C., Oliver, J., Renouf, D. V., Keston, M., and Pope, F. M. (1991) Substitution of cysteine for glycine at residue 415 of one allele of the α1(1) chain of type 1 procollagen in type III/IV osteogeneis imperfecta. J. Med. Genet. 28, 757-764.
14. Mottes, M., Gomez-Lira, M., Valli, M., Scarano, G., Lonardo, F., Forlino, A., Cetta, G., and Pignatti, P. F. (1993) Paternal mosaicism for a COL1A1 dominant mutation (α1 Ser-415) causes recurrent osteogenesis imperfecta. Hum. Mutat. 2, 196-204.
15. Valli, M., Rossi, A., Forlino, A., Tenni, R., and Cetta, G. (1993) Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. Matrix 13, 275-280.
16. Bateman, J., Moeller, I., Hannagan, M., Chan, D., and Cole, W. G. (1992) Characterisation of three osteogenesis imperfecta collagen α1(1) glycine to serine mutations demonstrating a position dependant gradient of phenotype severity. Biochem. J. 288, 131-135.
17. Fisher, L. W., Termine, J. D., and Young, M. F. (1989) Deduced protein sequence of bone small proteoglycan 1 (biglycan) shows homology with proteoglycan II (decorin) and several known non-connective proteins in a variety of species. J. Biol. Chem. 264, 4571-4576.
18. Bateman, J., and Golub, S. (1994) Deposition and selective degradation of structurally-abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro. Matrix Biol. 14, 251-262.
19. Cetta, G., Rossi, A., Tenni, R., Valli, M., Forlino, A., Zanaboni, G., Dyne, K. M., and Burgio, G. R. (1993) Deposition of mutant type I collagen in the extracellular matrix of cultures of dermal fibroblasts in osteogenesis imperfecta. Connect. Tissue Res. 29, 41-49.
20. Wessler, E. (1970) Electrophoretic separation of glycosaminoglycans excreted in excess in different kinds of "mucopolysaccharidoses." In "Chemistry and Molecular Biology of the Extracellular Matrix" (E. A. Balazs, Ed.), Academic Press, London/ New York.
21. Scott, J. E., and Bosworth, T. R. (1990) A comparative biochemical and ultrastructural study of proteglycan-collagen interactions in corneal stroma: Functional and metabolic implications. Biochem. J. 270, 491-497.
22. Woessner, J. F. (1961) The determination of hydroxyproline in tissue and protein samples containing small amounts of this amino acid. Arch. Biochem. Biophys. 93, 440-447.
23. Haigh, M., and Scott, J. E. (1986) A method for processing tissue sections for staining with Cupromeronic blue and other dyes, using CEC techniques, for light and electron microscopy. Basic Appl. Histochem. 30, 479-485.
24. Scott, J. E. (1988) Proteoglycan-fibrillar collagen interactions. Biochem. J. 252, 313-323.
25. Scott, J. E., and Haigh, M. (1988) Identification of specific binding sites of keratan sulphate and chondroitin/dermatan sulphate proteoglycans on collagen fibrils in cornea, using Cupromeronic blue in critical electrolyte concentration techniques. Biochem. J. 253, 607-610.
26. Kwan, K. M., Pang, M. K., Zhou, S., Cowan, S. K., Kong, R. Y., Pfordte, T., Olsen, B. R., Sillence, D. O., Tam, P. P., and Cheah, K. S. (1997) Abnormal compartmentalisation of cartilage matrix components in mice lacking collagen X: Implications for function. J. Cell Biol. 136, 459-471.
27. Rosati, R., Horan, G. S., Pinero, G. J., Garofalo, S., Keene, D. R., Horton, W. A., Vuorio, E., de Crombrugghe, B., and Behringer, R. R. (1994) Normal long bone growth and development in type X collagen-null mice. Nature Genet. 8, 129-134.
28. McIntosh, I., Abbott, M. H., and Francomano, C. A. (1995) Concentration of mutations causing Schmid metaphyseal chondrodysplasia in the C-terminal noncollagenous domain of type X collagen. Hum. Mutat. 5, 121-125.
29. Chan, D., Weng, Y. M., Hocking, A. M., Golub, S., McQuillan, D. J., and Bateman, J. F. (1996) Site-directed mutagenesis of type X collagen: Expression of alpha I (X) NC1,NC2 and helical mutations in vitro and in transfected cells. J. Biol. Chem. 271, 13566-13572.
30. Scott, J. E., Orford, C. R., and Hughes, E. W. (1981) Proteoglycan-collagen arrangements in developing rat tail tendon: An electron microscopical and biochemical study. Biochem. J. 195, 573-581.
31. Scott, J. E., and Parry, D. A. D. (1992) The control of collagen fibril diameters in connective tissues. Int. J. Biol. Macromol. 14, 292-293.
32. Scott, J. E. (1993) Nomenclature of dermatan/chondroitin glycans and their proteoglycans. In "Dermatan Sulphate Proteoglycans: Chemistry, Biology, Chemical Pathology" (J. E. Scott, Ed.) pp. 1-11, Portland Press (Biochemical Society), London.
33. IUPAC-IUBMB Joint Commission on Biochemical Nomenclature (JCBN) and Nomenclature Committee of IUBMB (NC-IUBMB) (1997) Newsletter 1996. Eur. J. Biochem. 247, 733-739.